New treatments for viral respiratory tract infections--opportunities and problems.
Snell
N J
NJ
Bayer Pharma, Stoke Court, Stoke Poges, Slough SL2 4LY, UK. noel.snell.ns@bayer.co.uk
D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D012141:Respiratory Tract Infections / Q000517:prevention & control* / Q000821:virology; D014780:Viruses / Q000187:drug effects*
D000998:Antiviral Agents